Adjuvant EGFR tyrosine kinase inhibitors in EGFR-mutant non-small cell lung cancer: still an investigational approach

Transl Lung Cancer Res. 2019 Dec;8(Suppl 4):S387-S390. doi: 10.21037/tlcr.2019.09.02.
No abstract available

Publication types

  • Editorial
  • Comment